KU Leuven boasts a rich tradition of education and research that dates back six centuries. The university offers a wide variety of programs for around 58.684 students and is currently by far the largest university in Belgium in terms of research funding and expenditure (EUR 476 million in 2018). The university is a charter member of LERU. In the Times Higher Education ranking KU Leuven is ranked as the 14th European university, while in the Reuters Top 100 of the World’s most innovative institutions, KU Leuven is listed as the first European university, for the fourth year in a row. KU Leuven also provides high-quality health care in its University Hospitals.
In Horizon 2020, KU Leuven currently has been approved more than 450 projects and is ranked fifth HES institution with regard to number of signed grants. KU Leuven takes up the 11th place of European HES institutions hosting ERC grants (as first legal signatories of the grant agreement). In Horizon 2020, we are involved in 82 Innovative Training Networks, ranking us first institution of higher education with regard to number of MSCA-ITNs and we are hosting 76 MSCA Individual Fellows.
This project is situated in the Department of Development and Regeneration of the Biomedical Sciences group. The Department has 24 professors and around 70 ongoing PhDs. The Locomotor and Neurological Disorders Group focuses amongst others on the unraveling of neuroplasticity, clinical outcome (improval) and rehabilitation potential in conditions such as Cerebral Palsy, Prematurity and its comorbidities.